Insider Trading History of Tzianabos Arthur


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tzianabos Arthur since year 2005. The trader's CIK number is 1586226. At the time of the last reporting, Tzianabos Arthur was the President & CEO of Homology Medicines, Inc. . (stock ticker symbol FIXX). See this page for all insider trading activities at Homology Medicines, Inc. .

Note that in the past TZIANABOS ARTHUR also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Tzianabos Arthur since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-10-01 FIXX Homology Medicines, Inc. Sale 12,500 17.81 222,624
2019-09-03 FIXX Homology Medicines, Inc. Sale 12,500 18.75 234,324
2019-08-01 FIXX Homology Medicines, Inc. Sale 12,500 17.37 217,112
2019-07-01 FIXX Homology Medicines, Inc. Sale 12,500 18.98 237,300
2019-06-03 FIXX Homology Medicines, Inc. Sale 12,500 19.86 248,262
2016-08-26 BIND Bind Therapeutics, Inc Option Ex 15,000 .44 6,600
2015-04-09 OVAS Ovascience, Inc. Buy 225 28.77 6,473
2015-04-08 OVAS Ovascience, Inc. Buy 175 28.04 4,907
2013-09-12 OVAS Ovascience, Inc. Buy 1,000 10.32 10,320

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tzianabos Arthur (President & CEO of Homology Medicines, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month